## Wound Infection and Delayed Healing in Diabetes ### Clinical Context This patient presents with a wound infection (purulent discharge, erythema, warmth) 10 days post-operatively, during the **inflammatory phase** (typically days 0–5, but can extend with complications). His poorly controlled diabetes (random glucose 280 mg/dL) is the key predisposing factor. ### Pathophysiology of Hyperglycaemia on Wound Healing **Key Point:** Hyperglycaemia impairs the inflammatory phase by: 1. **Neutrophil dysfunction** — reduced chemotaxis, phagocytosis, and oxidative burst 2. **Impaired opsonisation** — glycation of immunoglobulins reduces bacterial coating 3. **Reduced complement activation** — defective C3 and C5 function 4. **Increased bacterial adherence** — high glucose favours pathogen colonisation ### Why This Delays Healing | Phase | Normal Timeline | With Infection/Diabetes | Key Process | |-------|---|---|---| | **Inflammatory** | Days 0–5 | Days 0–14+ | Neutrophil infiltration, bacterial clearance, cytokine release | | **Proliferative** | Days 5–21 | Delayed onset | Fibroblast migration, collagen synthesis, angiogenesis | | **Remodelling** | Days 21–365+ | Prolonged | Collagen cross-linking, scar maturation | **Clinical Pearl:** The wound infection visible at day 10 (purulent discharge, separated edges) indicates **failure of the inflammatory phase** — the neutrophils have not effectively cleared bacteria, allowing secondary infection to establish. ### Additional Factors in This Patient - **Anaemia (Hb 9.2 g/dL)** — reduces oxygen delivery to the wound, impairing oxidative killing and collagen synthesis - **Hypoalbuminaemia (2.8 g/dL)** — impairs fibroblast function and collagen deposition in the proliferative phase - **Hyperglycaemia** — the PRIMARY driver of neutrophil dysfunction in the inflammatory phase **High-Yield:** Diabetic patients have a **3–5-fold increased risk** of surgical site infections (SSI) due to impaired neutrophil function, not just poor glycaemic control at the time of surgery. ### Management Implications 1. **Tight glycaemic control** (target 140–180 mg/dL perioperatively) 2. **Aggressive wound care** — debridement of necrotic tissue, drainage of pus 3. **Nutritional support** — albumin, vitamin C, zinc supplementation 4. **Antibiotic therapy** — broad-spectrum cover until culture results available
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.